rs28936396
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_000178.4(GSS):c.373C>T(p.Arg125Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,613,906 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000178.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GSS | NM_000178.4 | c.373C>T | p.Arg125Cys | missense_variant | 5/13 | ENST00000651619.1 | NP_000169.1 | |
GSS | NM_001322494.1 | c.373C>T | p.Arg125Cys | missense_variant | 5/13 | NP_001309423.1 | ||
GSS | NM_001322495.1 | c.373C>T | p.Arg125Cys | missense_variant | 5/13 | NP_001309424.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GSS | ENST00000651619.1 | c.373C>T | p.Arg125Cys | missense_variant | 5/13 | NM_000178.4 | ENSP00000498303 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152086Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251436Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135900
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461820Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 727220
GnomAD4 genome AF: 0.000243 AC: 37AN: 152086Hom.: 0 Cov.: 32 AF XY: 0.000323 AC XY: 24AN XY: 74294
ClinVar
Submissions by phenotype
Inherited glutathione synthetase deficiency Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 125 of the GSS protein (p.Arg125Cys). This variant is present in population databases (rs28936396, gnomAD 0.09%). This missense change has been observed in individual(s) with glutathione synthetase deficiency (PMID: 8896573, 11445798). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 8529). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GSS protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects GSS function (PMID: 8896573, 10861239). This variant disrupts the p.Arg125 amino acid residue in GSS. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 15717202, 26669244, 28267090). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 28, 2022 | Variant summary: GSS c.373C>T (p.Arg125Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.2e-05 in 251436 control chromosomes (gnomAD). This frequency is not higher than predicted for a pathogenic variant in GSS causing Glutathione Synthetase Deficiency (5.2e-05 vs 0.003), allowing no conclusion about variant significance. c.373C>T has been reported in the literature in individuals affected with Glutathione Synthetase Deficiency (examples: Shi_1996 and Firas Alqarajeh_2020 ). These data indicate that the variant may be associated with disease. Multiple reports have provided experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal activity (examples: Shi_1996 and Njalsson_2000). Other variant(s) that disrupt this residue have been reported to be associated with Glutathione synthetase deficiency (PMID 28267090). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 04, 2023 | - - |
Glutathione synthetase deficiency with 5-oxoprolinuria Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 1996 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at